Comparison of the role of mutant and wild-type FOXA1 in PCa growth showed that patients with FOXA1-mutated PCa had a poorer prognosis; furthermore, almost all FOXA1 mutants resulted in increased cancer cell growth compared with FOXA1 overexpression [76, 86–89]. The gene discussed is FOXA1; the disease is cancer.